Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
New Targets
100%
Metabolic
100%
Adenosine Monophosphate-activated Protein Kinase
100%
Antidiabetic Drug
100%
Skeletal muscle
33%
Type 2 Diabetes Mellitus (T2DM)
22%
Xylose
22%
Liver
22%
Fatty Acid Oxidation
22%
Blood Glucose
22%
Plasma Membrane
11%
Lipid Metabolism
11%
Drug Development
11%
Therapeutic Effect
11%
New Therapeutics
11%
Diabetic Mice
11%
Skeletal muscle Cells
11%
Failure Rate
11%
Regulatory Proteins
11%
Direct Interaction
11%
Energy Balance
11%
Dithioacetal
11%
Indirect Interactions
11%
Oral Antihyperglycemic Agents
11%
Acquired Resistance
11%
Glucose Transport
11%
Antihyperglycemic
11%
Metabolic Effects
11%
Glucose Transporter 4 (GLUT4)
11%
Cellular Energy
11%
Related Compounds
11%
Oral Antidiabetic Drugs
11%
Biguanidine
11%
Non-insulin
11%
Hexose Transporter
11%
Thiazolidinediones
11%
Glucose Metabolism
11%
Output Synthesis
11%
Triglyceride Synthesis
11%
Cholesterol Biosynthesis
11%
Insulin Requirement
11%
Intervention Strategies
11%
Therapeutic Interventions
11%
Diethyl
11%
Kinase Activator
11%
Master Switch
11%
Medicine and Dentistry
Antidiabetic Agent
100%
Adenosine Phosphate
100%
Protein Kinases
100%
Skeletal Muscle
33%
Maturity Onset Diabetes of the Young
22%
Fatty Acid Oxidation
22%
Blood Glucose
22%
Xylose
22%
Cell Energy
11%
Cell Membrane
11%
Diabetes Mellitus
11%
Therapy Effect
11%
Glucose Uptake
11%
Regulator Protein
11%
Energy Balance
11%
Skeletal Muscle Cell
11%
Glucose Transporter 4
11%
Phosphotransferase Activator
11%
Triacylglycerol
11%
Oral Antidiabetic Agent
11%
Glucose Metabolism
11%
Thiazolidinedione
11%
Hexose Transport
11%
Insulin
11%
Lipid Metabolism
11%
Side Effect
11%
Oral
11%
Glucose
11%
Cholesterol
11%
Pharmacology, Toxicology and Pharmaceutical Science
Antidiabetic Agent
100%
Adenosine Phosphate
100%
Protein Kinases
100%
Glucose
55%
Fatty Acid
22%
Xylose
22%
Maturity Onset Diabetes of the Young
22%
Drug Development
11%
Therapeutic Effect
11%
Regulator Protein
11%
Lipid
11%
Triacylglycerol
11%
Oral Antidiabetic Agent
11%
Thiazolidinedione
11%
Phosphotransferase Activator
11%
Glucose Transporter 4
11%
Diabetes Mellitus
11%
Insulin
11%
Side Effect
11%
Cholesterol
11%
Hexose
11%
Biochemistry, Genetics and Molecular Biology
Protein Kinases
100%
Adenosine Monophosphate
100%
Skeletal Muscle
44%
Beta Oxidation
22%
Glucose Blood Level
22%
Maturity Onset Diabetes of the Young
22%
Xylose
22%
Lipid Metabolism
11%
Triglyceride
11%
Glucose Transport
11%
Cell Energy
11%
Energy Balance
11%
Glucose Metabolism
11%
Hexose Transport
11%
Cell Membrane
11%
Thiazolidinedione
11%
Insulin
11%
Drug Development
11%
Glucose
11%
Cholesterol
11%
Regulatory Protein
11%
Glucose Transporter
11%